is 1.25 mg tirzepatide effective Dosing: Diabetes vs Weight Loss Compounded GLP-1 - Semaglutide &

A study known as FOCUS will evaluate the effects of semaglutide in addition to diabetes medication on diabetic retinopathy

Our latest report, Whos in control of GLP-1 prescribing doctors or PBMs

Deb Bossio, a naturopath and Lyme disease specialist with Naturally Well Family Medicine will be presenting in the Westport studio and Kristen Harris, Education Program Manager at the Global Lyme Alliance will present and educate in the Stamford studio

Tirzepatide, a dual GLP-1 and GIP receptor agonist, has emerged as a tool to help manage this weight gain by restoring appetite control and metabolic balance

The trial results To compare, recipients of high-dose Ozempic lost about the same amount of weight as the danuglipron study group over 30 weeks, according to Novo Nordisks Phase 3 study of the semaglutide injectable formulation

Tyanova, S., Temu, T